What does a 5-year total shareholder return (TSR) tell me about a stock?

TSR measures how much an investment in a stock would have earned over five years, including price appreciation and dividends. For PM, a 5-year TSR near 153% signals strong historical shareholder rewards, while for Unilever the TSR must be read in conjunction with its diversified consumer portfolio. TSR helps compare long-term performance, not future prospects, and should be viewed alongside other metrics.

How should I interpret a company undergoing a major restructuring?

A restructuring, such as separating U.S. and international operations, aims to sharpen strategic focus and accelerate growth opportunities. For PM, this may affect revenue streams, capital allocation, and risk profile. Investors should assess how the new structure could alter profitability, cash flow timings, and investor communications, rather than relying on prior operating models.

Why is dividend growth considered when evaluating a stock?

Dividend growth signals a company’s confidence in future cash flow and can contribute to total return. PM’s ongoing dividend increases point to robust financial health, while Unilever’s dividend stability reflects its mature, diversified business. However, dividend policy alone does not capture growth potential or risk, so it should be cross-checked with earnings, debt, and cash flow.

What is ROE and why is it important for comparing companies?

Return on equity (ROE) measures how efficiently a company uses shareholders’ funds to generate profit. A negative ROE, as noted for PM in recent years, suggests profitability challenges compared with peers. Unilever’s ROE around 20% indicates stronger capital efficiency. Interpreting ROE requires considering industry norms, risk, and capital structure.

How should price-to-earnings (P/E) ratios influence my view of PM and Unilever?

A high P/E can reflect strong growth expectations embedded in the price. PM trading at a high P/E relative to the tobacco industry may indicate optimism about its transition to smoke-free products; conversely, Unilever’s P/E should be weighed against its mature consumer staples positioning. Always compare P/E with peers, growth drivers, and risk factors.

What does market sentiment tell me about near-term prospects?

Bearish market sentiment for PM implies potential near-term price declines despite long-term potential. For Unilever, sentiment would hinge on consumer demand, input costs, and margins. Market sentiment is a short-term indicator; it should be integrated with fundamental analysis, including cash flow, debt load, and strategic milestones.

Which business model aspects should I compare between PM and Unilever?

PM relies on a tobacco-oriented, smoke-free strategy with a large capital base and dividend focus, while Unilever operates a diversified consumer goods platform across food and personal care. Compare revenue diversification, cost structure, capital expenditure needs, and exposure to regulatory and commodity risks to understand each model’s resilience.

How do sector dynamics affect a tobacco company versus a consumer goods company?

Tobacco firms face regulatory scrutiny, changing consumer trends, and potential long-term decline in smoking prevalence, affecting growth and margins. Consumer goods companies depend on consumer demand, commodity costs, and branding power across multiple categories. Sector dynamics shape growth potential, risk exposure, and resilience to economic cycles.

What role do macroeconomic factors play in these two stocks?

Macroeconomic factors like inflation, currency movements, and consumer spending trends influence both, but in different ways. PM’s margins may be sensitive to regulatory costs and combustible alternatives, while Unilever’s input costs and discretionary spending can sway profitability. Understanding macro risks helps contextualise company-specific signals.

How should I use this comparison page when evaluating PM versus Unilever?

Treat the page as a structured view of business models, financial health, and market context. Read the pros and cons to gauge strengths and risks for each stock, then examine how revenue sources, profitability, and capital allocation align with your goals. Use it as a starting point for deeper fundamental research.

Is there a single metric that can definitively rank PM against Unilever?

No single metric offers a definitive ranking. A holistic view requires multiple metrics: TSR, ROE, P/E, dividend policy, debt, cash flow, and growth catalysts. Consider how each stock’s strengths and risks fit your investment framework and time horizon, rather than relying on isolated numbers.

What does the educational disclaimer on this page mean for me as a reader?

The page provides educational content to help readers understand how to read and compare stocks. It does not offer personalised financial advice or endorsements. Always conduct your own research or consult a professional before making investment decisions, especially given differing risk profiles.

Philip Morris International vs Unilever

Global tobacco giant shifting to smoke free products vs Global household and personal care brands powerhouse. Which is the better buy for your portfolio in July 2026? Plain-English answer below.

Philip Morris International has reinvented itself around smoke-free nicotine products like IQOS and Zyn, aggressively repositioning its revenue base away from combustible cigarettes, while Unilever manages a vast portfolio of consumer staples brands spanning food, home care, and personal products across every major market on earth. Both companies are global consumer giants navigating brand investment, pricing power, and category evolution in developed and emerging markets simultaneously. Philip Morris International vs Unilever contrasts a focused transformation story with a diversified portfolio conglomerate, revealing where the more compelling organic growth and margin expansion thesis actually sits.

Philip Morris International has reinvented itself around smoke-free nicotine products like IQOS and Zyn, aggressively repositioning its revenue base away from combustible cigarettes, while Unilever ma...

Comparison Snapshot

Key Financial Metrics

PM

Metric

UL

$280.84B

Market Cap

$131.78B

-10.86%

Potential Profit

21.75%

Buy

Analyst Rating

Buy

Why It’s Moving

Philip Morris Faces Downside Risk as Analysts Weigh Earnings Beat Against Cost Pressures and Slower Product Approval Timeline

Analysts are cautioning that despite a recent Q3 earnings beat with $10.85B revenue and $2.24 EPS, the stock faces downside risk due to elevated cost pressures and heavy investment spending that may weigh on future margins.
CEO Jacek Olczak's reaffirmation of strict FDA compliance, while positive for regulatory credibility, signals a potentially slower timeline for new nicotine product approvals, limiting immediate growth catalysts.
The stock has shown minimal momentum over the past 12 months with only a 0.3% gain, and recent trading data indicates a 2.22% drop in the last 24 hours, reflecting investor skepticism about near-term upside.

Sentiment:

🐻Bearish

Sentiment:

⚖️Neutral

Philip Morris Faces Downside Risk as Analysts Weigh Earnings Beat Against Cost Pressures and Slower Product Approval Timeline

Analysts are cautioning that despite a recent Q3 earnings beat with $10.85B revenue and $2.24 EPS, the stock faces downside risk due to elevated cost pressures and heavy investment spending that may weigh on future margins.
CEO Jacek Olczak's reaffirmation of strict FDA compliance, while positive for regulatory credibility, signals a potentially slower timeline for new nicotine product approvals, limiting immediate growth catalysts.
The stock has shown minimal momentum over the past 12 months with only a 0.3% gain, and recent trading data indicates a 2.22% drop in the last 24 hours, reflecting investor skepticism about near-term upside.

Sentiment:

🐻Bearish

Sentiment:

⚖️Neutral

Discover More Comparisons

Philip Morris International vs Honeywell

Philip Morris International is remaking itself into a smoke-free company with a portfolio of heated tobacco and oral nicotine products generating rapid volume and pricing gains, while Honeywell operates a sprawling industrial conglomerate spanning aerospace components, building controls, and performance materials. Both are global blue-chip companies with strong pricing power and international revenue exposure, navigating very different transformation stories. Philip Morris International vs Honeywell examines organic growth rates, margin expansion potential, and capital allocation discipline to clarify which large-cap industrial or consumer staples franchise creates more shareholder value over the next five years.

Philip Morris International vs PepsiCo

Philip Morris International sells combustible and smoke-free tobacco products in markets outside the U.S. and has aggressively pivoted toward heated tobacco and pouches, while PepsiCo runs a global snacks-and-beverages empire anchored by Lay's chips and Pepsi-Cola with steadier organic growth. Both are consumer-staples heavyweights that lean on brand power, pricing discipline, and generous dividends to reward long-term holders. Philip Morris International vs PepsiCo forces a comparison between a nicotine-product transformation story and a diversified food-and-beverage compounder on margins, leverage, and capital return.

Philip Morris International vs AB InBev

Philip Morris International pivots aggressively toward smoke-free products like IQOS, collecting margin-rich revenue from consumers switching away from cigarettes, while AB InBev dominates global beer with a portfolio of iconic brands and a balance sheet still carrying the debt load from the SABMiller mega-merger. Both companies sell legal consumer vices through global distribution networks that competitors can't easily replicate. The Philip Morris International vs AB InBev comparison digs into transformation progress, deleveraging trajectories, and which consumer staples giant earns its premium valuation.

Investment Analysis

Philip Morris International

PM

Pros

Philip Morris International (PM) has a strong 5-year total shareholder return of nearly 153%, reflecting long-term investor rewards from strategic shifts toward smoke-free products.
The company is undergoing a major corporate restructuring in 2026 to separate U.S. and international operations, aiming to accelerate growth in smoke-free categories.
PM has a significant market capitalization of over $233 billion and continues to increase its dividend, highlighting robust financial health and shareholder returns.

Considerations

Philip Morris International's return on equity (ROE) has been negative over recent years, indicating challenges in profitability compared to peers like Unilever.
Current market sentiment for PM is bearish with price forecasts predicting a potential decline of around 9% by the end of 2025, suggesting near-term valuation risks.
The stock trades at a high price-to-earnings ratio well above the global tobacco industry average, which could imply the current price already incorporates strong growth expectations.

Unilever

UL

Pros

Unilever is a leading international consumer goods company with a strong global footprint, including significant exposure to fast-growing markets in Asia Pacific and Africa.
The company benefits from a diversified portfolio across food, personal care, and household products, providing stability against sector-specific risks.
Unilever maintains a solid return on equity around 20%, indicating efficient use of capital and profitable operations relative to many peers.

Considerations

Unilever faces structural competitive pressures and evolving consumer preferences, which may affect its growth momentum in mature markets.
Exposure to volatile commodity prices and inflationary pressures can impact input costs and margins, posing challenges to near-term profitability.
The company's growth trajectory is less dynamic compared to high-growth sectors, which could limit upside potential relative to companies undergoing significant transformation.

Related Market Insights

The Recession-Proof Portfolio: Why These Stocks Thrive When Markets Crumble

Discover recession-proof stocks that thrive in economic downturns. Build a stable, defensive portfolio with essential goods companies. Invest with Nemo's curated Neme.

Aimee Silverwood | Financial Analyst

25 July 2025

Read Insight

Stagflation Standouts: The Defensive Plays Thriving While Markets Stumble

Navigate stagflation with Nemo's "Stagflation Standouts" Neme. Invest in defensive stocks & gold designed to thrive when growth stalls & inflation persists.

Aimee Silverwood | Financial Analyst

25 July 2025

Read Insight

Sin Stocks: The Recession-Proof Investment Strategy Nobody Talks About

Discover sin stocks in alcohol, tobacco & gaming for recession-proof returns. Stable demand, steady dividends & growth. Invest with Nemo's curated Neme.

Philip Morris International (PM) is expected to report its next earnings on July 22, 2026, before the market opens. This report will cover the fiscal quarter ending June 2026, which corresponds to Q2 2026. Analysts project an EPS of approximately $2.03 to $2.05 for this quarter, based on current consensus forecasts. The company has not yet officially confirmed the date, but it aligns with its historical reporting schedule.

Unilever (UL) Next Earnings Date

Unilever PLC (UL) is expected to release its next earnings report on July 28, 2026. This upcoming announcement will cover the company's Q2 2026 results as well as its Half-Year 2026 financial performance. The date has been confirmed by the company in its upcoming results calendar for investors. Investors should note that this schedule reflects the firm's official filing plan for the second quarter of the year.

Philip Morris International (PM) Next Earnings Date

Philip Morris International (PM) is expected to report its next earnings on July 22, 2026, before the market opens. This report will cover the fiscal quarter ending June 2026, which corresponds to Q2 2026. Analysts project an EPS of approximately $2.03 to $2.05 for this quarter, based on current consensus forecasts. The company has not yet officially confirmed the date, but it aligns with its historical reporting schedule.

Unilever (UL) Next Earnings Date

Unilever PLC (UL) is expected to release its next earnings report on July 28, 2026. This upcoming announcement will cover the company's Q2 2026 results as well as its Half-Year 2026 financial performance. The date has been confirmed by the company in its upcoming results calendar for investors. Investors should note that this schedule reflects the firm's official filing plan for the second quarter of the year.

Which Baskets Do They Appear In?

Sin Stocks

This carefully selected group of stocks represents leading companies in alcohol, tobacco, and gaming industries. These companies tend to perform steadily regardless of economic conditions, making them valuable additions to your portfolio during uncertain times.

Published: 17 June 2025

Explore Basket

Stagflation Standouts

This collection features stocks and assets carefully selected by professional analysts to potentially outperform during stagflation periods. These defensive investments have already shown strength while the broader market struggles, making them worth consideration for economic uncertainty ahead.

Published: 19 May 2025

Explore Basket

Top Stocks for Recessions

These carefully selected stocks have shown remarkable resilience during economic downturns. Our team of professional analysts has identified companies that maintain stability when markets get shaky, giving you options for weathering financial storms.

These carefully selected stocks have shown remarkable resilience during economic downturns. Our team of professional analysts has identified companies that maintain stability when markets get shaky, giving you options for weathering financial storms.

Published: 3 May 2025

Explore Basket

Philip Morris International vs Unilever

Comparison Snapshot

Why It’s Moving

Philip Morris Faces Downside Risk as Analysts Weigh Earnings Beat Against Cost Pressures and Slower Product Approval Timeline

Philip Morris Faces Downside Risk as Analysts Weigh Earnings Beat Against Cost Pressures and Slower Product Approval Timeline